Skip to main content
logo
COSCIENS Biopharma Inc. (LON:0UGB)
London flag London · Delayed Price · Currency is GBP · Price in CAD
4.200
-0.050 (-1.18%)
At close: Jan 22, 2025

COSCIENS Biopharma Revenue

COSCIENS Biopharma had revenue of $2.75M USD in the quarter ending June 30, 2025, with 17.63% growth. This brings the company's revenue in the last twelve months to $9.44M, up 24.89% year-over-year. In the year 2024, COSCIENS Biopharma had annual revenue of $9.59M with 34.22% growth.

Revenue (ttm)
$9.44M
Revenue Growth
+24.89%
P/S Ratio
0.88
Revenue / Employee
$236.05K
Employees
40
Market Cap
6.10M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.59M2.44M34.22%
Dec 31, 20237.14M-7.43M-50.98%
Dec 31, 202214.57M9.31M177.03%
Dec 31, 20215.26M1.61M44.03%
Dec 31, 20203.65M3.12M586.47%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Shell200.18B
BP p.l.c.138.32B
Unilever51.24B
HSBC Holdings43.13B
AstraZeneca41.24B
Rio Tinto Group39.22B
GSK plc32.17B
British American Tobacco p.l.c.25.60B
Revenue Rankings

COSCIENS Biopharma News

More News